1. Home
  2. PMI vs BNGO Comparison

PMI vs BNGO Comparison

Compare PMI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PMI

Picard Medical Inc.

HOLD

Current Price

$0.15

Market Cap

14.1M

Sector

N/A

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.13

Market Cap

12.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMI
BNGO
Founded
1981
2003
Country
United States
United States
Employees
75
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
12.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
PMI
BNGO
Price
$0.15
$1.13
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
6.3M
132.0K
Earning Date
06-18-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
N/A
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$0.11
$1.06
52 Week High
$13.68
$5.50

Technical Indicators

Market Signals
Indicator
PMI
BNGO
Relative Strength Index (RSI) 37.92 42.99
Support Level $0.15 $1.13
Resistance Level $0.27 $1.19
Average True Range (ATR) 0.02 0.04
MACD 0.01 0.00
Stochastic Oscillator 18.51 21.43

Price Performance

Historical Comparison
PMI
BNGO

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: